News

2019

11|29

AROMICS selected at the accelerator program InvestHorizon

AROMICS is among the companies selected in the second edition of the InvestHorizon Acceleration Programme, which will host 55 companies in the next 4-6 months. InvestHorizon is an accelerator program designed to facilitate access to Series A financing...
  read whole news

2019

11|15

Working day on asbestos and its impact in human health

  On the 15th November 2019, the first scientific working session on asbestos and its consequences in health will take place. It is a scientific day aimed to discuss about different aspects of the diseases directly associated...
  read whole news

Working day on asbestos and its impact in human health

2019

11|11

Aromics at 7th mRNA Health Conference in Berlin

Dr. Carme Plasencia, CEO of Aromics presented  on 11-12 November the progress of the BERMES Project funded by the European Union's Horizon 2020 programme at the 7th International mRNA Health Conference. The conference...
  read whole news

Aromics at 7th mRNA Health Conference in Berlin

2019

10|25

Aromics selected for the InvestHorizon Acceleration Programme

AROMICS is on the companies selected on the sеcond round of the InvestHorizon Acceleration Programme that will accommodate 55 companies within the next 4-6 months. InvestHorizon is an accelerator programme designed to facilitate the access...
  read whole news

Aromics selected for the InvestHorizon Acceleration Programme

2019

10|01

AROMICS will be present at the Sino-Europe Innovation Week of Health Technology

Dr. Carmen Plasencia, CEO of AROMICS will attend next month (from 13.10.19 till 16.10.19) to the 2019 SIWHT, Sino-EU Innovation Week of Health Technology, taking place in the most innovative area of Shenzhen, Nanjing and Shanghai in China. The...
  read whole news

AROMICS will be present at the Sino-Europe Innovation Week of Health Technology

2019

09|26

2nd META-CAN Workshop

AROMICS is one of the participants of META-CAN, a multidisciplinary coordinated EU funded project that studies the involvement of metabolism and immune system in cancer in order to unveil new therapeutic targets. 2nd META-CAN Workshop was...
  read whole news

2nd META-CAN Workshop

2019

07|12

Aromics at LaBiotech Journal : Using ‘Omics’ to Develop Treatments for Drug-Resistant Cancer

Labiotech.eu, the leading digital media covering the European Biotech industry with over 150,000 monthly visitors, has selected AROMICS as one of the biotechs in Europe leading with OMIC technologies and its application to drug discovery and...
  read whole news

Aromics at LaBiotech Journal : Using ‘Omics’ to Develop Treatments for Drug-Resistant Cancer

2019

11|20

AROMICS' CEO present at the SME instrument Wellcome Day

AROMICS Chief Executive Officer and co-founder,  Dr. Carmen Plasencia, was one participants in the event organized by the European Innovation Council (EIC) pilot dedicated to SME Phase 2 Insturment funded projects.  The company...
  read whole news

AROMICS' CEO present at the SME instrument Wellcome Day

2019

04|01

AROMICS renews the Seal for Innovative SMEs

The Spanish Ministry of Science, Innovation and Universities recognized the innovation and advances of Aromics in developing novel therapies for highly unmet medical needs. The seal awards companies that have proven, with its trajectory and activity,...
  read whole news

AROMICS renews the Seal for Innovative SMEs